ketoconazole has been researched along with sulfacetamide in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Abdulla, FR; Brodell, RT | 1 |
Kaithwas, G; Kishor, K; Sahu, RK; Saraf, SA; Singh, B | 1 |
4 other study(ies) available for ketoconazole and sulfacetamide
Article | Year |
---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Seborrheic dermatitis. The link between facial rash and neurologic disease.
Topics: Anti-Infective Agents, Local; Antifungal Agents; Dermatitis, Seborrheic; Humans; Ketoconazole; Male; Middle Aged; Multiple Sclerosis; Sulfacetamide | 2005 |
Photochemical toxicity of drugs intended for ocular use.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Chickens; Diclofenac; Eye Diseases; Humans; Irritants; Ketoconazole; Ketorolac; Ophthalmic Solutions; Photochemical Processes; Sulfacetamide; Voriconazole | 2014 |